Evidence map›Paper›PMID 39190217›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2024

White adipose tissue remodeling in Little Brown Myotis (Myotis lucifugus) with white-nose syndrome.

Evan L Pannkuk, Marianne S Moore, Shivani Bansal, Kamendra Kumar, Shubhankar Suman, Daryl Howell, Joseph A Kath, Allen Kurta, DeeAnn M Reeder, Kenneth A Field

Abstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Evan L PannkukDepartment of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, 3970 Reservoir Road, NW, New Research Building, Room E504, Washington, DC, 20057, USA. elp44@georgetown.edu.
Marianne S MooreDepartment of Biological Sciences, University of the Virgin Islands, St. Thomas, USA.
Shivani BansalDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Kamendra KumarDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Shubhankar SumanDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Daryl HowellIowa Department of Natural Resources, Des Moines, IA, USA.
Joseph A KathIllinois Department of Natural Resources, Springfield, IL, USA.
Allen KurtaDepartment of Biology, Eastern Michigan University, Ypsilanti, MI, USA.
DeeAnn M ReederDepartment of Biology, Bucknell University, Lewisburg, PA, USA.
Kenneth A FieldDepartment of Biology, Bucknell University, Lewisburg, PA, USA.

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI MARCUS S NOEL · 1990 to 2026
$71.5M
NCI NIH HHS P30 CA051008NCI NIH HHS P30CA051008U.S. Department of the Interior (USFWS) F11AP00073U.S. Department of the Interior (USFWS) F20AP12285-00
6 · The paper itself

Abstract

White-nose syndrome (WNS) is a fungal wildlife disease of bats that has caused precipitous declines in certain Nearctic bat species. A key driver of mortality is premature exhaustion of fat reserves, primarily white adipose tissue (WAT), that bats rely on to meet their metabolic needs during winter. However, the pathophysiological and metabolic effects of WNS have remained ill-defined. To elucidate metabolic mechanisms associated with WNS mortality, we infected a WNS susceptible species, the Little Brown Myotis (Myotis lucifugus), with Pseudogymnoascus destructans (Pd) and collected WAT biopsies for histology and targeted lipidomics. These results were compared to the WNS-resistant Big Brown Bat (Eptesicus fuscus). A similar distribution in broad lipid class was observed in both species, with total WAT primarily consisting of triacylglycerides. Baseline differences in WAT chemical composition between species showed that higher glycerophospholipids (GPs) levels in E. fuscus were dominated by unsaturated or monounsaturated moieties and n-6 (18:2, 20:2, 20:3, 20:4) fatty acids. Conversely, higher GP levels in M. lucifugus WAT were primarily compounds containing n-3 (20:5 and 22:5) fatty acids. Following Pd-infection, we found that perturbation to WAT reserves occurs in M. lucifugus, but not in the resistant E. fuscus. A total of 66 GPs (primarily glycerophosphocholines and glycerophosphoethanolamines) were higher in Pd-infected M. lucifugus, indicating perturbation to the WAT structural component. In addition to changes in lipid chemistry, smaller adipocyte sizes and increased extracellular matrix deposition was observed in Pd-infected M. lucifugus. This is the first study to describe WAT GP composition of bats with different susceptibilities to WNS and highlights that recovery from WNS may require repair from adipose remodeling in addition to replenishing depot fat during spring emergence.

Indexed as

Adipose Tissue, WhiteAscomycotaChiropteraMycosesAnimalsLipidomicsBatsEptesicus fuscusIpidomicsLiquid chromatographyMass spectrometryMyotis lucifugusWhite-nose syndrome

Identifiers

PMID39190217
PMCPMC13154016

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.